MatriSys Bioscience

Harnessing beneficial bacteria to treat chronic inflammatory skin conditions.

[MatriSys Bioscience @MatriSysBio]

MatriSys announces positive results from a study of S. felis for the treatment of drug-resistant S. pseudintermedius. https://t.co/CFFzSe46NA https://t.co/D6redQSh4Q #dermatology #skinmicrobiome

[MatriSys Bioscience @MatriSysBio]

Dr. Philippe Calais, CEO of @MatriSysBio, will be presenting at the @MicrobiomeDaily 4th Microbiome Movement – Skin Health & Dermatology Summit (https://t.co/EkzTufFQJt) on August 4th at 4:15 p.m. ET. https://t.co/l4rlxvWCM6

[MatriSys Bioscience @MatriSysBio]

We are pleased to announce that Dr. Joyce Rico is joining MatriSys as Chief Medical Officer. Dr. Rico’s 20 years of experience in early and late-stage #dermatology drug development, product launch, and drug safety is a welcome addition to our team.

[MatriSys Bioscience @MatriSysBio]

MatriSys Bioscience licenses compound for harnessing beneficial bacteria to treat #acne, building upon company pipeline targeting inflammatory skin diseases. https://t.co/nrhEuoHBt6 #dermatology #skinmicrobiome

[MatriSys Bioscience @MatriSysBio]

MatriSys Bioscience raises more than $3 million to advance its platform developing #skinmicrobiome therapies for inflammatory skin diseases. #dermatology

[MatriSys Bioscience @MatriSysBio]

Published @NatureMedicine study on @MatriSysBio’s lead compound for #atopicdermatitis reveals the potential of beneficial bacteria to treat chronic skin diseases. https://t.co/2c6P3u5x6n #dermatology #microbiome

[MatriSys Bioscience @MatriSysBio]

Important new science from the NIH - How genetic variations cause eczema https://t.co/jUw4VHE01S

[MatriSys Bioscience @MatriSysBio]

MatriSys Bioscience, Inc., a leader in the field of microbiome-based therapeutics is pleased to announce that it was named a 2020 “Cool Company” by Connect/San Diego Venture Group (SDVG). https://t.co/Nsi5h2jbG1

[MatriSys Bioscience @MatriSysBio]

MatriSys Bioscience Inc. is pleased to announce that Magda Marquet PhD has been appointed Chairwoman of MatriSys’ Board of Directors https://t.co/2u5iWQuSFF

[MatriSys Bioscience @MatriSysBio]

MatriSys Bioscience is pleased to announce the appointment of Dr. James Mackay to its Board of Directors https://t.co/JzQ7eGiBIw

[MatriSys Bioscience @MatriSysBio]

https://t.co/qJGAG2UUEg

[MatriSys Bioscience @MatriSysBio]

This is an important concept. Colonization is not the same thing as infection. Bleach baths and antibiotics aren't very effective against colonized bacteria. Acne is a good model to explain this. https://t.co/wx2tSDvMI3

[MatriSys Bioscience @MatriSysBio]

MatriSys Bioscience announces successful FDA Pre-IND review and Phase 2 plans for MSB-01, a revolutionary human-microbiome based treatment
for Atopic Dermatitis. The positive feedback received from the FDA is encouraging and paves the way for Phase 2.
https://t.co/uoIwfpxe38

[MatriSys Bioscience @MatriSysBio]

MatriSys Bioscience Inc. has appointed longtime life science executive Jennifer Giottonini Cayer to its Board of Directors. Ms. Cayer brings more than 25 years of leadership experience spanning biotech, pharmaceutical and medical devices. https://t.co/dJVBb1SjjI

[MatriSys Bioscience @MatriSysBio]

MatriSys Bioscience, Inc., a leader in the field of microbiome-based therapeutics for the treatment of skin conditions, announced today that it has submitted a pre-IND (Investigational New Drug) meeting request letter to the U.S. FDA for planned Phase 2 https://t.co/tTm161WXq6

[MatriSys Bioscience @MatriSysBio]

https://t.co/9yuU8IeUW0

[MatriSys Bioscience @MatriSysBio]

Tonight!! San Diego Central Library CITIZEN SCIENCE: MatriSys Bioscience https://t.co/gHWyzWnubG

[MatriSys Bioscience @MatriSysBio]

Thursday night at the San Diego Public Library!! https://t.co/THpLJeqgxD

[MatriSys Bioscience @MatriSysBio]

BioCentury!! https://t.co/UjqGdmHTYa

[MatriSys Bioscience @MatriSysBio]

Buzz of Bio!! Vote for us!!

How to vote for us:

Go here: https://t.co/9bIEBgQdra
Complete each field on the right side of the page
Be sure to select MatriSys Bioscience under Pipelines of Promise
Hit submit
Follow the link in the confirmation email to verify your vote